Variant report

Variant	esv3490569
Chromosome Location	chr4:166680129-166981346
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:166935776-166935910	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:166904046-166904529	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:166913562-166913762	HepG2	liver:	n/a	n/a
4	ATF2	chr4:166966554-166967053	GM12878	blood:	n/a	n/a
5	BACH1	chr4:166680436-166680445	K562	blood:	n/a	n/a
6	BACH1	chr4:166794608-166795071	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCL3	chr4:166709916-166710217	GM12878	blood:	n/a	n/a
8	BHLHE40	chr4:166795983-166796175	K562	blood:	n/a	chr4:166796057-166796066 chr4:166796057-166796066 chr4:166796058-166796067 chr4:166796089-166796105
9	BRCA1	chr4:166795824-166796343	H1-hESC	embryonic stem cell:	n/a	n/a
10	BRCA1	chr4:166795838-166796025	Hela-S3	cervix:	n/a	n/a
11	BRCA1	chr4:166892938-166893532	Hela-S3	cervix:	n/a	n/a
12	BRCA1	chr4:166826773-166827241	Hela-S3	cervix:	n/a	n/a
13	CBX3	chr4:166887906-166888359	HCT-116	colon:	n/a	n/a
14	CBX3	chr4:166795718-166796406	HCT-116	colon:	n/a	n/a
15	CCNT2	chr4:166961202-166961347	K562	blood:	n/a	n/a
16	CCNT2	chr4:166794517-166794732	K562	blood:	n/a	n/a
17	CEBPB	chr4:166683190-166683390	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr4:166971100-166971131	K562	blood:	n/a	n/a
19	CEBPB	chr4:166935612-166935908	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr4:166687008-166687323	HepG2	liver:	n/a	chr4:166687158-166687175 chr4:166687161-166687172
21	CEBPB	chr4:166927396-166927738	IMR90	lung:	n/a	chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927577-166927590
22	CEBPB	chr4:166927426-166927740	ECC-1	luminal epithelium:	n/a	chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927577-166927590
23	CEBPB	chr4:166891839-166892720	Hela-S3	cervix:	n/a	n/a
24	CEBPB	chr4:166933496-166934178	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr4:166927394-166927731	ECC-1	luminal epithelium:	n/a	chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927577-166927590
26	CEBPB	chr4:166753307-166753468	HepG2	liver:	n/a	chr4:166753370-166753381 chr4:166753371-166753382
27	CEBPB	chr4:166900252-166900495	K562	blood:	n/a	chr4:166900360-166900371
28	CEBPB	chr4:166798497-166798784	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr4:166778892-166779007	K562	blood:	n/a	chr4:166778994-166779005
30	CEBPB	chr4:166900196-166900511	IMR90	lung:	n/a	chr4:166900360-166900371
31	CEBPB	chr4:166927428-166927759	K562	blood:	n/a	chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927577-166927590
32	CEBPB	chr4:166892991-166893429	HCT-116	colon:	n/a	n/a
33	CEBPB	chr4:166970261-166970475	IMR90	lung:	n/a	chr4:166970377-166970388
34	CEBPB	chr4:166687021-166687341	IMR90	lung:	n/a	chr4:166687158-166687175 chr4:166687161-166687172
35	CEBPB	chr4:166892943-166893529	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr4:166778863-166779076	MCF-7	breast:	n/a	chr4:166778994-166779005
37	CEBPB	chr4:166778825-166779170	H1-hESC	embryonic stem cell:	n/a	chr4:166778994-166779005
38	CEBPB	chr4:166893040-166893432	ECC-1	luminal epithelium:	n/a	n/a
39	CEBPB	chr4:166778849-166778895	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr4:166893025-166893467	ECC-1	luminal epithelium:	n/a	n/a
41	CEBPB	chr4:166927423-166927707	A549	lung:	n/a	chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927577-166927590
42	CEBPB	chr4:166686308-166686621	Hela-S3	cervix:	n/a	chr4:166686595-166686608
43	CEBPB	chr4:166778847-166779175	K562	blood:	n/a	chr4:166778994-166779005
44	CEBPB	chr4:166970252-166970536	HepG2	liver:	n/a	chr4:166970377-166970388
45	CEBPB	chr4:166927405-166927734	H1-hESC	embryonic stem cell:	n/a	chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927579-166927588 chr4:166927577-166927590
46	CEBPB	chr4:166687028-166687330	A549	lung:	n/a	chr4:166687158-166687175 chr4:166687161-166687172
47	CEBPB	chr4:166826232-166827203	Hela-S3	cervix:	n/a	n/a
48	CEBPB	chr4:166778833-166779044	A549	lung:	n/a	chr4:166778994-166779005
49	CEBPB	chr4:166912443-166912782	Hela-S3	cervix:	n/a	n/a
50	CEBPB	chr4:166900354-166900391	H1-hESC	embryonic stem cell:	n/a	chr4:166900360-166900371

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:166794786-166794836	AG09309	skin:	n/a
2	chr4:166794786-166794836	AG09309	skin:	n/a
3	chr4:166791090-166791140	H1-hESC	embryonic stem cell:	embryo
4	chr4:166794971-166795021	HCM	heart:	n/a
5	chr4:166795323-166795373	LNCaP	prostate:	n/a
6	chr4:166795773-166795823	A549	lung:	n/a
7	chr4:166793789-166793839	HAEpiC	amniotic membrane:	n/a
8	chr4:166958874-166958924	HRPEpiC	eye:	n/a
9	chr4:166720738-166720788	PANC-1	pancreas:	n/a
10	chr4:166794786-166794836	PrEC	prostate:	n/a
11	chr4:166794786-166794836	BJ	skin:	n/a
12	chr4:166795401-166795451	ProgFib	skin:	n/a
13	chr4:166797526-166797576	Jurkat	blood:	n/a
14	chr4:166795323-166795373	T-47D	breast:	n/a
15	chr4:166794267-166794317	BE2_C	brain:	n/a
16	chr4:166795649-166795699	GM06990	blood:	n/a
17	chr4:166797526-166797576	ProgFib	skin:	n/a
18	chr4:166795401-166795451	T-47D	breast:	n/a
19	chr4:166795649-166795699	GM12892	blood:	n/a
20	chr4:166794895-166794945	HCM	heart:	n/a
21	chr4:166795913-166795963	NB4	blood:	n/a
22	chr4:166795401-166795451	HEEpiC	esophagus:	n/a
23	chr4:166797526-166797576	HCF	heart:	n/a
24	chr4:166791090-166791140	HIPEpiC	eye:	n/a
25	chr4:166795773-166795823	MCF-7	breast:	n/a
26	chr4:166794786-166794836	RPTEC	kidney:	n/a
27	chr4:166795323-166795373	BJ	skin:	n/a
28	chr4:166794895-166794945	MCF10A-Er-Src	breast:	n/a
29	chr4:166795773-166795823	IMR90	lung:	fetal
30	chr4:166794471-166794521	MCF10A-Er-Src	breast:	n/a
31	chr4:166795913-166795963	HPAEpiC	pulmonary alveolar:	n/a
32	chr4:166794471-166794521	HNPCEpiC	eye:	n/a
33	chr4:166795773-166795823	HUVEC	blood vessel:	n/a
34	chr4:166794971-166795021	T-47D	breast:	n/a
35	chr4:166793789-166793839	MCF10A-Er-Src	breast:	n/a
36	chr4:166797526-166797576	Hela-S3	cervix:	n/a
37	chr4:166794786-166794836	HEEpiC	esophagus:	n/a
38	chr4:166720738-166720788	HMEC	breast:	n/a
39	chr4:166795622-166795672	K562	blood:	n/a
40	chr4:166795649-166795699	LNCaP	prostate:	n/a
41	chr4:166795524-166795574	ProgFib	skin:	n/a
42	chr4:166794786-166794836	MCF10A-Er-Src	breast:	n/a
43	chr4:166795260-166795310	ProgFib	skin:	n/a
44	chr4:166797526-166797576	BE2_C	brain:	n/a
45	chr4:166791090-166791140	HEEpiC	esophagus:	n/a
46	chr4:166794471-166794521	AG10803	skin:	n/a
47	chr4:166795401-166795451	K562	blood:	n/a
48	chr4:166795401-166795451	HMEC	breast:	n/a
49	chr4:166797526-166797576	HIPEpiC	eye:	n/a
50	chr4:166794206-166794256	HPAEpiC	pulmonary alveolar:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:166458106..166458875-chr4:166702316..166703340,5	MCF-7	breast:
2	chr4:166774942..166777729-chr4:166780158..166782137,2	K562	blood:
3	chr4:166785202..166785812-chr4:167011963..167012826,2	MCF-7	breast:
4	chr4:166689759..166692649-chr4:166704291..166705799,2	K562	blood:
5	chr4:166697213..166699912-chr4:166708730..166710362,2	K562	blood:
6	chr4:166678013..166679693-chr4:166681397..166683849,2	K562	blood:
7	chr4:166959625..166962088-chr4:166969549..166972503,2	K562	blood:
8	chr4:166905947..166907624-chr4:166909376..166911122,2	K562	blood:
9	chr4:166774942..166777729-chr4:166780158..166782137,2	K562	blood:
10	chr4:166790628..166793456-chr4:166794269..166796859,3	K562	blood:
11	chr4:166458088..166458621-chr4:166702621..166703139,2	MCF-7	breast:
12	chr4:166905947..166907624-chr4:166909376..166911122,2	K562	blood:
13	chr4:166721869..166724664-chr4:166726820..166728345,2	K562	blood:
14	chr4:166959625..166962088-chr4:166969549..166972503,2	K562	blood:
15	chr4:166689759..166692649-chr4:166704291..166705799,2	K562	blood:
16	chr4:166658631..166660297-chr4:166687744..166690707,2	K562	blood:
17	chr4:166721869..166724664-chr4:166726820..166728345,2	K562	blood:
18	chr4:166697213..166699912-chr4:166708730..166710362,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TLL1-1	chr4:166682408-166683930	XLOC_003770

Variant related genes	Relation type
TLL1	TF binding region
RNA5SP170	TF binding region
TLL1	CpG island
RNA5SP170	CpG island
ENSG00000038295	chromatin interactions

Extended variants
information (count: 11328 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:11328 , 50 per page) page: 1 2 3 4 5 6 7 ... 227

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs547656565	chr4:166680161-166680162	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs542122794	chr4:166680203-166680204	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs553722269	chr4:166680217-166680218	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs565724934	chr4:166680274-166680275	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs35471176	chr4:166680289-166680290	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs536404667	chr4:166680315-166680316	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs554767412	chr4:166680346-166680347	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs185532041	chr4:166680358-166680359	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs368377110	chr4:166680404-166680405	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs537086862	chr4:166680463-166680464	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs576962703	chr4:166680475-166680476	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs148790074	chr4:166680491-166680492	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs142275692	chr4:166680542-166680543	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs541317074	chr4:166680591-166680592	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs553211012	chr4:166680599-166680600	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs12108366	chr4:166680615-166680616	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs12108367	chr4:166680625-166680626	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs560833895	chr4:166680634-166680635	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs545804534	chr4:166680650-166680651	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs543469623	chr4:166680679-166680680	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs146775086	chr4:166680688-166680689	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs187004685	chr4:166680757-166680758	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs547721540	chr4:166680780-166680781	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs192242122	chr4:166680832-166680833	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs111638733	chr4:166680835-166680836	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs115896830	chr4:166680894-166680895	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs548351599	chr4:166680937-166680938	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs541842723	chr4:166680980-166680981	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs537147430	chr4:166681068-166681069	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs140633721	chr4:166681070-166681071	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs550736189	chr4:166681142-166681143	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs534655035	chr4:166681147-166681148	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs553274486	chr4:166681193-166681194	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs575041668	chr4:166681335-166681336	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs376584319	chr4:166681381-166681382	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs557507804	chr4:166681445-166681446	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs576102040	chr4:166681458-166681459	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs561698482	chr4:166681459-166681460	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs369580094	chr4:166681474-166681475	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs184079449	chr4:166681527-166681528	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs372279324	chr4:166681528-166681529	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs145692695	chr4:166681534-166681535	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs146735640	chr4:166681554-166681555	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs533503887	chr4:166681561-166681562	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs77299944	chr4:166681591-166681592	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs559425272	chr4:166681623-166681624	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs529980768	chr4:166681638-166681639	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs369349391	chr4:166681642-166681643	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs187812967	chr4:166681647-166681648	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs530578615	chr4:166681648-166681649	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Glioblastoma multiforme	22286061	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	16774939	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Myelofibrosis	22110671	CNVD
intellectual deficit	22127048	CNVD
abnormal development	18461090	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:915 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:166662600-166685000	Weak transcription	HMEC	breast
2	chr4:166668200-166681600	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr4:166679000-166681200	Weak transcription	Fetal Muscle Leg	muscle
4	chr4:166679000-166681400	Enhancers	iPS-20b Cell Line	embryonic stem cell
5	chr4:166679000-166681600	Enhancers	HUES48 Cell Line	embryonic stem cell
6	chr4:166679200-166681200	Weak transcription	HUES6 Cell Line	embryonic stem cell
7	chr4:166679400-166680600	Enhancers	iPS-18 Cell Line	embryonic stem cell
8	chr4:166679400-166682400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
9	chr4:166679600-166681400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
10	chr4:166679600-166684200	Weak transcription	Fetal Heart	heart
11	chr4:166679800-166680600	Weak transcription	HUES64 Cell Line	embryonic stem cell
12	chr4:166680600-166681400	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr4:166681200-166681600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr4:166681200-166681600	Enhancers	HUES6 Cell Line	embryonic stem cell
15	chr4:166681200-166681800	Enhancers	Fetal Muscle Leg	muscle
16	chr4:166681400-166681600	Enhancers	ES-I3 Cell Line	embryonic stem cell
17	chr4:166681400-166681800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
18	chr4:166681600-166681800	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr4:166681600-166684800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
20	chr4:166681600-166685000	Weak transcription	HUES48 Cell Line	embryonic stem cell
21	chr4:166681800-166682600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr4:166681800-166684800	Weak transcription	Fetal Muscle Leg	muscle
23	chr4:166682600-166684400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr4:166683000-166683200	Enhancers	Hela-S3	cervix
25	chr4:166683200-166686600	Weak transcription	Hela-S3	cervix
26	chr4:166683800-166685600	Enhancers	Adipose Nuclei	Adipose
27	chr4:166684200-166685400	Enhancers	Fetal Heart	heart
28	chr4:166684200-166686000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr4:166684200-166687000	Enhancers	HUVEC	blood vessel
30	chr4:166684400-166684800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr4:166684800-166685200	Enhancers	Fetal Muscle Leg	muscle
32	chr4:166684800-166685400	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr4:166684800-166686000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr4:166685000-166685200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr4:166685000-166685400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr4:166685000-166685600	Enhancers	HMEC	breast
37	chr4:166685400-166686400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr4:166685400-166686600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
39	chr4:166685600-166686600	Weak transcription	Adipose Nuclei	Adipose
40	chr4:166685600-166686600	Weak transcription	HMEC	breast
41	chr4:166686000-166686200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
42	chr4:166686000-166686400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr4:166686400-166686800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr4:166686400-166687000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr4:166686600-166686800	Enhancers	Adipose Nuclei	Adipose
46	chr4:166686600-166686800	Enhancers	HMEC	breast
47	chr4:166686600-166687400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
48	chr4:166686600-166687400	Enhancers	Hela-S3	cervix
49	chr4:166687000-166687200	Flanking Active TSS	HUVEC	blood vessel
50	chr4:166687200-166687600	Enhancers	HUVEC	blood vessel

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links